Dr. Sumit Madan, MD

Dr. Madan practices at Banner Gateway Medical Center in Gilbert, Arizona, part of Banner Health.

Dr. Madan's NPI, 1972766756, was assigned on July 2, 2008. Dr. Madan holds Texas license Q1211.

Dr. Madan's primary practice is Banner Gateway Medical Center, at 1900 North Higley Road, Gilbert, AZ 85234 in Maricopa County. The practice phone is (480) 543-2000.

Dr. Madan's primary practice is Banner Gateway Medical Center in Gilbert, Arizona, part of Banner Health. Dr. Madan is also affiliated with Banner Thunderbird Medical Center. The medical group on file is Banner Cancer Center Specialists LLC. Dmand AI also links Dr. Madan to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Madan practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Madan's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Madan is licensed in Texas.

CMS data shows 682 Medicare services from Dr. Madan across 9 procedure codes in 2024, for 231 Medicare patients. Medicare paid $58,096 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 231 Medicare patients who saw Dr. Madan in 2024. The largest group is 65 to 74, with 114 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 2.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Madan's median patient age at 71, with 47% women.

In 2024, Dr. Madan wrote 1,043 Medicare Part D claims for 151 patients. 71% of them were for generic drugs. CMS names the drug for 875 of them, across 17 drugs with 11 or more claims each, at $6,139,274 in total drug cost. In 2023, CMS named 926 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 78 out of 100 for Dr. Madan for performance year 2024, reported as part of a group. Dr. Madan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 38 papers to Dr. Madan, published from 2011 to 2025. 2022 was the busiest year, with 7. The most frequent topics are Data Mining, Neural Networks, Computer and COVID-19. Dr. Madan has published most often in Database (Oxford). Dr. Madan's most frequent co-authors are Muhamed Baljevic, MD, William Ira Bensinger, MD and Noa Biran, MD.

Dmand AI links Dr. Madan to 5 clinical trials, 2 of them phase 1 studies. 3 are still active or recruiting. Conditions studied include Multiple Myeloma, Blood Protein Disorders and Carcinoma, Merkel Cell. Open Payments lists research payments to Dr. Madan that name 1 trial.

CMS Open Payments shows 880 general payments to Dr. Madan from 26 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 71% of the total. Janssen Pharmaceuticals, Inc paid the most, $266,481. It also lists 10 research payments totaling $3,867 from 2017 to 2025, naming 1 clinical trial.